HOOKIPA Pharma Inc. (HOOK)
$1.15+0.00%Close
SELLBULL · day 5
Key stats
- Market cap
- $14M
- Beta
- 0.77
- P/E (TTM)
- -1.06
- 1W
- +0.00%
- 1M
- +0.00%
- vs SPY 1W
- +0.14%
- vs SPY 1M
- -2.51%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 18
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-19.8%
REV YoY-
ROE-33.0%
EPS YoY-
ROA-33.1%
GROSS93
OP-377
NET-143
[VALUATION]
P/E TTM-1.06
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B0.45
P/FCF-
EV/EBITDA0.64
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.42
ALTMAN Z-
CURR RATIO6.35
ND/EBITDA-
BETA0.77
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on HOOK?
- LOPJLB’s latest quantitative signal on HOOKIPA Pharma Inc. (HOOK) is SELL in a BULL regime. Signals are updated daily.
- What market regime is HOOK in?
- HOOKIPA Pharma Inc. (HOOK) is currently classified in the BULL HMM market regime on LOPJLB.
- What does HOOKIPA Pharma Inc. (HOOK) do?
- HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The companyâs immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic ca…